Intangible Assets

12 Months Ended

Jan. 02, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

9. Intangible Assets, net

Intangible assets, net, consist of the following (in thousands):


	January 2, 2021		December 28, 2019
Gross carrying amount
Acquired technologies	$	29,039	$	5,580
Patents	26,875		23,242
Customer relationships	24,666		7,669
Trademarks	11,708		4,614
Licenses-related party	7,500		7,500
Capitalized software development costs	3,710		3,328
Other	7,091		5,466
Total gross carrying amount	$	110,589	$	57,399
Accumulated amortization
Patents	$	(10,763)	$	(9,251)
Licenses-related party	(6,841)		(5,984)
Customer relationships	(6,486)		(5,688)
Acquired technologies	(5,259)		(4,182)
Trademarks	(3,999)		(2,195)
Capitalized software development costs	(2,319)		(2,137)
Other	(999)		(711)
Total accumulated amortization	(36,666)		(30,148)
Net carrying amount	$	73,923	$	27,251

Intangible assets have a weighted-average amortization period of twelve years. For the years ended January 2, 2021, December 28, 2019 and December 29, 2018, amortization of intangible assets was $7.5 million, $4.4 million and $4.8 million, respectively. As of January 2, 2021 and December 28, 2019, the total costs of patents not yet amortizing was $8.2 million and $6.1 million, respectively. As of January 2, 2021 and December 28, 2019, the total costs of trademarks not yet amortizing was $0.9 million and $0.7 million, respectively.

For the years ended January 2, 2021 and December 28, 2019, total renewal costs capitalized for patents and trademarks was $1.3 million and $1.3 million, respectively. As of January 2, 2021, the weighted-average number of years until the next renewal was one year for patents and six years for trademarks.

During the first quarter of fiscal 2020, the Company completed an immaterial business combination. Based on the Company’s preliminary purchase price allocation, approximately $15.5 million, $2.6 million and $1.7 million of the purchase price was assigned to customer relationships, acquired technologies and trademarks, respectively.

During the second quarter of fiscal 2020, the Company completed another immaterial business combination. Based on the Company’s preliminary purchase price allocation, approximately $6.3 million, $2.4 million, $0.4 million and $0.3 million of the purchase price was assigned to acquired technologies, trademarks, customer relationships and other intangibles, respectively.

During the fourth quarter of fiscal 2020, the Company obtained a controlling interest in a provider of advanced hemodynamic monitoring solutions. Based on the Company’s preliminary purchase price allocation, approximately $14.0 million, $2.3 million, $1.0 million and $1.0 million of the purchase price was assigned to acquired technologies, trademarks, customer relationships and other intangibles, respectively. Subsequently, during the first quarter of fiscal 2021, the Company acquired the remaining minority interest. See Note 14 to these consolidated financial statements for further details.

The Company is still gathering additional information to finalize these preliminary estimates with respect to tax contingency matters and expects to finalize the purchase price allocations as soon as practicable, but no later than one year from the acquisition dates.

Estimated amortization expense for each of the next fiscal years is as follows (in thousands):


Fiscal year	Amount
2021	$	8,761
2022	8,385
2023	7,334
2024	6,985
2025	5,974
Thereafter	36,484
Total	$	73,923